Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference
The annual ImmunoRad Conference has established itself as a recurrent occasion to explore the possibility of combining radiation therapy (RT) and immunotherapy (IT) for clinical cancer management. Bringing together a number of preclinical and clinical leaders in the fields of radiation oncology, imm...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | OncoImmunology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2025.2507856 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850151402605641728 |
|---|---|
| author | Fereshteh Talebi Fabiana Gregucci Jalal Ahmed Nir Ben Chetrit Brian D. Brown Timothy A. Chan Dhan Chand Julie Constanzo Sandra Demaria Dmitry I. Gabrilovich Encouse Golden Andrew Godkin Chandan Guha Gaorav P. Gupta Aisha Hasan Fernanda G. Herrera Howard Kaufman Donna Li Alan A. Melcher Sierra McDonald Taha Merghoub Arta M. Monjazeb Sébastien Paris Sean Pitroda Anguraj Sadanandam Dörthe Schaue Laura Santambrogio Phillippe Szapary Julien Sage James W. Welsh Anna Wilkins Kristina H. Young Eric Wennerberg Laurence Zitvogel Lorenzo Galluzzi Eric Deutsch Silvia C. Formenti |
| author_facet | Fereshteh Talebi Fabiana Gregucci Jalal Ahmed Nir Ben Chetrit Brian D. Brown Timothy A. Chan Dhan Chand Julie Constanzo Sandra Demaria Dmitry I. Gabrilovich Encouse Golden Andrew Godkin Chandan Guha Gaorav P. Gupta Aisha Hasan Fernanda G. Herrera Howard Kaufman Donna Li Alan A. Melcher Sierra McDonald Taha Merghoub Arta M. Monjazeb Sébastien Paris Sean Pitroda Anguraj Sadanandam Dörthe Schaue Laura Santambrogio Phillippe Szapary Julien Sage James W. Welsh Anna Wilkins Kristina H. Young Eric Wennerberg Laurence Zitvogel Lorenzo Galluzzi Eric Deutsch Silvia C. Formenti |
| author_sort | Fereshteh Talebi |
| collection | DOAJ |
| description | The annual ImmunoRad Conference has established itself as a recurrent occasion to explore the possibility of combining radiation therapy (RT) and immunotherapy (IT) for clinical cancer management. Bringing together a number of preclinical and clinical leaders in the fields of radiation oncology, immuno-oncology and IT, this annual event fosters indeed essential conversations and fruitful exchanges on how to address existing challenges to expand the therapeutic value of RT-IT combinations. The 8th edition of the ImmunoRad Conference, which has been held in October 2024 at the Weill Cornell Medical College of New York City, highlighted exciting preclinical and clinical advances at the interface between RT and IT, setting the stage for extra progress toward extended benefits for patients with an increasing variety of tumor types. Here, we critically summarize the lines of investigation that have been discussed at the occasion of the 8th Annual ImmunoRad Conference. |
| format | Article |
| id | doaj-art-e1500e40ca2344059a6524ff86d40910 |
| institution | OA Journals |
| issn | 2162-402X |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | OncoImmunology |
| spelling | doaj-art-e1500e40ca2344059a6524ff86d409102025-08-20T02:26:18ZengTaylor & Francis GroupOncoImmunology2162-402X2025-12-0114110.1080/2162402X.2025.2507856Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad ConferenceFereshteh Talebi0Fabiana Gregucci1Jalal Ahmed2Nir Ben Chetrit3Brian D. Brown4Timothy A. Chan5Dhan Chand6Julie Constanzo7Sandra Demaria8Dmitry I. Gabrilovich9Encouse Golden10Andrew Godkin11Chandan Guha12Gaorav P. Gupta13Aisha Hasan14Fernanda G. Herrera15Howard Kaufman16Donna Li17Alan A. Melcher18Sierra McDonald19Taha Merghoub20Arta M. Monjazeb21Sébastien Paris22Sean Pitroda23Anguraj Sadanandam24Dörthe Schaue25Laura Santambrogio26Phillippe Szapary27Julien Sage28James W. Welsh29Anna Wilkins30Kristina H. Young31Eric Wennerberg32Laurence Zitvogel33Lorenzo Galluzzi34Eric Deutsch35Silvia C. Formenti36Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USADepartment of Radiation Oncology, Weill Cornell Medicine, New York, NY, USAIcahn Genomics Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USADepartment of Radiation Oncology, Weill Cornell Medicine, New York, NY, USAIcahn Genomics Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USADepartment of Cancer Sciences, Global Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USAAgenus Inc, Lexingston, MA, USAInstitut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier (ICM), Montpellier, FranceDepartment of Radiation Oncology, Weill Cornell Medicine, New York, NY, USAAstraZeneca, Gaithersburg, MD, USADepartment of Radiation Oncology, Weill Cornell Medicine, New York, NY, USADivision of Infection and Immunity/Systems Immunity University Research Institute, School of Medicine, Cardiff University, Cardiff, UKDepartments of Radiation Oncology and Pathology, Albert Einstein College of Medicine, New York, NY, USADepartment of Radiation Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAJohnson & Johnson, New Brunswick, NJ, USAAGORA Cancer Research Center, Swiss Cancer Center Leman, Lausanne, SwitzerlandAnkyra Therapeutics, Cambridge, MA, USAUniversity of Wisconsin, Madison, WI, USADivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKUNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USASwim Across America and Ludwig Collaborative Laboratory, Department of Pharmacology, Weill Cornell Medicine, New York, NY, USADepartment of Radiation Oncology, University of California, San Diego, CA, USANanobiotix, Paris, FranceDepartment of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, University of Chicago, Chicago, IL, USADivision of Molecular Pathology, The Institute of Cancer Research, London, UKDepartment of Radiation Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USADepartment of Radiation Oncology, Weill Cornell Medicine, New York, NY, USAInterventional Oncology, Johnson & Johnson, New Brunswick, NJDepartments of Genetics and Pediatrics, Stanford University, Stanford, CaliforniaDepartment of Radiation Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USADivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKDivision of Radiation Oncology, The Oregon Clinic, Portland, OR, USADivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UKGustave Roussy, INSERM U1015, Division of Medicine, Paris-Saclay University, Center of Clinical Investigations BIOTHERIS, Villejuif, FranceCancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USADepartment of Radiation Oncology, Gustave Roussy, INSERM U1030, Division of Medicine, Paris-Saclay University, RHU LySAIRI “Lymphocyte-Sparing Artificial Intelligence-guided Radio-Immunotherapy”, Villejuif, FranceDepartment of Radiation Oncology, Weill Cornell Medicine, New York, NY, USAThe annual ImmunoRad Conference has established itself as a recurrent occasion to explore the possibility of combining radiation therapy (RT) and immunotherapy (IT) for clinical cancer management. Bringing together a number of preclinical and clinical leaders in the fields of radiation oncology, immuno-oncology and IT, this annual event fosters indeed essential conversations and fruitful exchanges on how to address existing challenges to expand the therapeutic value of RT-IT combinations. The 8th edition of the ImmunoRad Conference, which has been held in October 2024 at the Weill Cornell Medical College of New York City, highlighted exciting preclinical and clinical advances at the interface between RT and IT, setting the stage for extra progress toward extended benefits for patients with an increasing variety of tumor types. Here, we critically summarize the lines of investigation that have been discussed at the occasion of the 8th Annual ImmunoRad Conference.https://www.tandfonline.com/doi/10.1080/2162402X.2025.2507856Abscopal effectCAR T cellsCD8+ cytotoxic T lymphocyteslow-dose radiation therapyTREG cellstumor-associated macrophages |
| spellingShingle | Fereshteh Talebi Fabiana Gregucci Jalal Ahmed Nir Ben Chetrit Brian D. Brown Timothy A. Chan Dhan Chand Julie Constanzo Sandra Demaria Dmitry I. Gabrilovich Encouse Golden Andrew Godkin Chandan Guha Gaorav P. Gupta Aisha Hasan Fernanda G. Herrera Howard Kaufman Donna Li Alan A. Melcher Sierra McDonald Taha Merghoub Arta M. Monjazeb Sébastien Paris Sean Pitroda Anguraj Sadanandam Dörthe Schaue Laura Santambrogio Phillippe Szapary Julien Sage James W. Welsh Anna Wilkins Kristina H. Young Eric Wennerberg Laurence Zitvogel Lorenzo Galluzzi Eric Deutsch Silvia C. Formenti Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference OncoImmunology Abscopal effect CAR T cells CD8+ cytotoxic T lymphocytes low-dose radiation therapy TREG cells tumor-associated macrophages |
| title | Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference |
| title_full | Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference |
| title_fullStr | Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference |
| title_full_unstemmed | Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference |
| title_short | Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference |
| title_sort | updates on radiotherapy immunotherapy combinations proceedings of 8th annual immunorad conference |
| topic | Abscopal effect CAR T cells CD8+ cytotoxic T lymphocytes low-dose radiation therapy TREG cells tumor-associated macrophages |
| url | https://www.tandfonline.com/doi/10.1080/2162402X.2025.2507856 |
| work_keys_str_mv | AT fereshtehtalebi updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT fabianagregucci updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT jalalahmed updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT nirbenchetrit updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT briandbrown updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT timothyachan updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT dhanchand updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT julieconstanzo updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT sandrademaria updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT dmitryigabrilovich updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT encousegolden updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT andrewgodkin updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT chandanguha updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT gaoravpgupta updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT aishahasan updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT fernandagherrera updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT howardkaufman updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT donnali updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT alanamelcher updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT sierramcdonald updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT tahamerghoub updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT artammonjazeb updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT sebastienparis updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT seanpitroda updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT angurajsadanandam updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT dortheschaue updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT laurasantambrogio updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT phillippeszapary updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT juliensage updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT jameswwelsh updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT annawilkins updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT kristinahyoung updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT ericwennerberg updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT laurencezitvogel updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT lorenzogalluzzi updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT ericdeutsch updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference AT silviacformenti updatesonradiotherapyimmunotherapycombinationsproceedingsof8thannualimmunoradconference |